IMMUNITAS THERAPEUTICS Trademark

Trademark Overview

On Wednesday, December 18, 2019, a trademark application was filed for IMMUNITAS THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the IMMUNITAS THERAPEUTICS trademark a serial number of 88731770. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, July 24, 2023. This trademark is owned by Immunitas Therapeutics, Inc.. The IMMUNITAS THERAPEUTICS trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Pharmaceutical research and development

General Information

Serial Number88731770
Word MarkIMMUNITAS THERAPEUTICS
Filing DateWednesday, December 18, 2019
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, July 24, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, April 28, 2020

Trademark Statements

Description of MarkThe mark consists of two concentric three-quarter circles formed with dashes and dots, with the last quarter-circle on the top right formed by single large dots. The word "Immunitas" in large font extends from within the center of the circles and "THERAPEUTICS" in small font is outside of the semi-circles below the letters "munitas".
Indication of Colors claimedColor is not claimed as a feature of the mark.
NOT AVAILABLE"THERAPEUTICS"
Goods and ServicesPharmaceutical research and development

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateSaturday, December 21, 2019
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameImmunitas Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressWaltham, MA 02451
Party NameImmunitas Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02142

Trademark Events

Event DateEvent Description
Saturday, December 21, 2019NEW APPLICATION ENTERED
Saturday, December 21, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, December 24, 2019NOTICE OF DESIGN SEARCH CODE E-MAILED
Tuesday, March 17, 2020ASSIGNED TO EXAMINER
Tuesday, March 17, 2020EXAMINERS AMENDMENT -WRITTEN
Tuesday, March 17, 2020EXAMINERS AMENDMENT E-MAILED
Tuesday, March 17, 2020NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, March 17, 2020EXAMINER'S AMENDMENT ENTERED
Tuesday, March 17, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, March 23, 2020ASSIGNED TO LIE
Wednesday, April 8, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 28, 2020PUBLISHED FOR OPPOSITION
Tuesday, April 28, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 23, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, December 16, 2020SOU TEAS EXTENSION RECEIVED
Wednesday, December 16, 2020SOU EXTENSION 1 FILED
Wednesday, December 16, 2020SOU EXTENSION 1 GRANTED
Friday, December 18, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, June 21, 2021SOU TEAS EXTENSION RECEIVED
Monday, June 21, 2021SOU EXTENSION 2 FILED
Monday, June 21, 2021SOU EXTENSION 2 GRANTED
Wednesday, June 23, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, December 20, 2021SOU TEAS EXTENSION RECEIVED
Monday, December 20, 2021SOU EXTENSION 3 FILED
Monday, December 20, 2021SOU EXTENSION 3 GRANTED
Wednesday, December 22, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, May 6, 2022SOU TEAS EXTENSION RECEIVED
Friday, May 6, 2022SOU EXTENSION 4 FILED
Friday, May 6, 2022SOU EXTENSION 4 GRANTED
Tuesday, May 10, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, December 1, 2022SOU TEAS EXTENSION RECEIVED
Thursday, December 1, 2022TEAS REQUEST TO DIVIDE RECEIVED
Thursday, December 1, 2022DIVISIONAL REQUEST RECEIVED
Thursday, December 1, 2022SOU EXTENSION 5 FILED
Tuesday, January 3, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, January 3, 2023DIVISIONAL PROCESSING COMPLETE
Tuesday, January 3, 2023SOU EXTENSION 5 GRANTED
Wednesday, January 4, 2023CORRECTED NOA E-MAILED
Wednesday, January 4, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, July 24, 2023ABANDONMENT - NO USE STATEMENT FILED
Monday, July 24, 2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED

Related Keywords

therapeutics immunitas development research pharmaceutical